OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evaluating NSAIDs in SARS-CoV-2: Immunomodulatory mechanisms and future therapeutic strategies
Said Moshawih, Qais Jarrar, Abdul Alim Bahrin, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25734-e25734
Open Access | Times Cited: 5
Said Moshawih, Qais Jarrar, Abdul Alim Bahrin, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25734-e25734
Open Access | Times Cited: 5
Showing 5 citing articles:
Cytokine Storm in COVID-19: Exploring IL-6 Signaling and Cytokine-Microbiome Interactions as Emerging Therapeutic Approaches
Tudorița Gabriela Părângă, Ivona Mitu, Mariana Pavel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11411-11411
Open Access | Times Cited: 6
Tudorița Gabriela Părângă, Ivona Mitu, Mariana Pavel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11411-11411
Open Access | Times Cited: 6
Natural products: A potential immunomodulators against inflammatory-related diseases
Telukuntla Sai Priya, Vaikundamoorthy Ramalingam, Katragadda Suresh Babu
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2821-2859
Closed Access | Times Cited: 2
Telukuntla Sai Priya, Vaikundamoorthy Ramalingam, Katragadda Suresh Babu
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2821-2859
Closed Access | Times Cited: 2
RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial
Olga Holubovska, Pavlo Babich, Alla Mironenko, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 3, pp. 202-217
Open Access | Times Cited: 1
Olga Holubovska, Pavlo Babich, Alla Mironenko, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 3, pp. 202-217
Open Access | Times Cited: 1
Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme
Gianfranco Sabadini, Marco Mellado, Cesar A. Morales, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 606-606
Open Access | Times Cited: 1
Gianfranco Sabadini, Marco Mellado, Cesar A. Morales, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 606-606
Open Access | Times Cited: 1
Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia
Denise Siegrist, Hulda R. Jónsdóttir, Mendy Bouveret, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1262-1262
Open Access
Denise Siegrist, Hulda R. Jónsdóttir, Mendy Bouveret, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1262-1262
Open Access
